Cairo – Mubasher: Egyptian International Pharmaceutical Industries (EIPICO) posted an increase of 24.6% in net profits for the first nine months of 2016.
The drug firm profits surged to EGP 368.02 million for the nine – month period ended September 2016, up from EGP 295.2 million for the same period of 2015.
Earlier, EIPICO unveiled its earnings for the first half of 2016, where it reported net profits of EGP 234.09 million up by 31.11% y-o-y.
